top of page

Clinical Evidence

Validation through data

Field Medical is committed to advancing the science and safety of cardiac arrhythmia treatment through rigorous clinical research. Because every breakthrough in cardiac care starts with bold research, our ongoing trials in PFA are designed to expand the role of PFA in treating VT and AF, offering new hope for patients worldwide.

This is a replay of a previously recorded scientific symposium hosted by Field Medical at Heart Rhythm 2025. The event marked one of the most attended satellite symposia at the meeting, featuring eight expert presenters exploring the future of ventricular tachycardia (VT) ablation.

Peer-Reviewed Publication

Circulation - October 10, 2025

High-Voltage Focal Pulsed Field Ablation to Treat Scar-Related Ventricular Tachycardia: The First-in-Human VCAS Trial.

Vivek Y. Reddy, MD; Petr Neuzil, MD, PhD; et al.

First published clinical data on pulsed field ablation in ventricular tachycardia.

82%

freedom from VT/VF recurrence

98%

reduction in VT/VF burden

0

device-related serious adverse events reported

Late-Breaking Clinical Trial Presentations

AF Symposium 2026

Field PULSE — First-in-Human Feasibility Data
Presented during Late Breaking Clinical Trials Session I

VCAS — Six-Month Clinical Outcomes

Selected for late-breaking presentation at the International Symposium on Ventricular Arrhythmias.

Clinical Trials

Field Medical’s clinical evaluations are publicly registered and organized by study intent.

VERITAS Scar VT — Pivotal Study

Enrollment anticipated 2026. For more information, email info@fieldmedicalinc.com

VERITAS Steering Committee

Dr. Pierre Jais Professor at the Cardiology Hospital, Pessac, France | Dr. Josef Kautzner Head of Department at Institute for Clinical and Experimental Medicine, Prague, Czech Republic | Dr. Jacob Koruth Cardiology Specialist, The Mount Sinai Hospital, New York, NY | Dr. Frank Marchlinski Hospital of the University of Pennsylvania, Philadelphia, PA | Dr. Andrea Natale Texas Cardiac Arrhythmia Institute, Austin TX | Dr. Vivek Reddy Director of Cardiac Arrhythmia Services, The Mount Sinai Hospital, New York, NY | Dr. Pasquale Santangeli Cleveland Clinic, Cleveland, OH | Dr. William Stevenson Vanderbilt Health, Nashville TN | Dr. Roderick Tung University of Arizona College of Medicine–Phoenix and Banner, University Medical Center, Phoenix, AZ | Dr. Wendy Tzou University of Colorado Anschutz, Aurora, CO | Dr. Atul Verma Southlake Regional Health Care Centre, Newmarket, Ontario, Canada

Ventricular Catheter Ablation Study (VCAS)

The Field PULSE Study — First-in-Human Feasibility Study

+1 (980) 412-2298​​​

1910 Palomar Point Way, Suite 101
Carlsbad, CA 92008​​​

​​​​CAUTION—Investigational device. Limited by Federal (or United States) law to investigational use.

Follow Us On:

  • LinkedIn
  • X
  • Youtube

Pulsed Field Ablation (PFA) 

Ventricular Tachycardia (VT)

Atrial Fibrillation (AF)

bottom of page